These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 35254140
1. Correlation between Identification of β-Lactamase Resistance Genes and Antimicrobial Susceptibility Profiles in Gram-Negative Bacteria: a Laboratory Data Analysis. Mushtaq A, Chasan R, Nowak MD, Rana M, Ilyas S, Paniz-Mondolfi AE, Sordillo EM, Patel G, Gitman MR. Microbiol Spectr; 2022 Apr 27; 10(2):e0148521. PubMed ID: 35254140 [Abstract] [Full Text] [Related]
2. Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip. El Aila NA, Al Laham NA, Ayesh BM. BMC Infect Dis; 2023 Feb 20; 23(1):99. PubMed ID: 36803466 [Abstract] [Full Text] [Related]
4. Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel. McCarty TP, Cumagun P, Meeder J, Moates D, Edwards WS, Hutchinson J, Lee RA, Leal SM. Microbiol Spectr; 2023 Feb 14; 11(1):e0409222. PubMed ID: 36688641 [Abstract] [Full Text] [Related]
5. Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia. Zeynudin A, Pritsch M, Schubert S, Messerer M, Liegl G, Hoelscher M, Belachew T, Wieser A. BMC Infect Dis; 2018 Oct 20; 18(1):524. PubMed ID: 30342476 [Abstract] [Full Text] [Related]
6. In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial. Stewart AG, Cottrell K, Henderson A, Vemuri K, Bauer MJ, Paterson DL, Harris PNA. Microbiol Spectr; 2021 Sep 03; 9(1):e0022621. PubMed ID: 34232101 [Abstract] [Full Text] [Related]
8. Extended Spectrum Beta Lactamase (ESBL), blaTEM,blaSHV and blaCTX-M, Resistance Genes in Community and Healthcare Associated Gram Negative Bacteria from Osun State, Nigeria. Shitta G, Makanjuola O, Adefioye O, Olowe OA. Infect Disord Drug Targets; 2021 Sep 03; 21(4):595-602. PubMed ID: 32729432 [Abstract] [Full Text] [Related]
9. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan. Abrar S, Vajeeha A, Ul-Ain N, Riaz S. Microb Pathog; 2017 Feb 03; 103():8-12. PubMed ID: 27956216 [Abstract] [Full Text] [Related]
10. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Yang Q, Zhang H, Cheng J, Xu Z, Xu Y, Cao B, Kong H, Ni Y, Yu Y, Sun Z, Hu B, Huang W, Wang Y, Wu A, Feng X, Liao K, Shen D, Hu Z, Chu Y, Lu J, Su J, Gui B, Duan Q, Zhang S, Shao H. Int J Antimicrob Agents; 2015 May 03; 45(5):485-90. PubMed ID: 25600890 [Abstract] [Full Text] [Related]
13. Evaluation of an expanded antibiotic resistance gene panel on prediction of antimicrobial susceptibility results for Gram-negative bacteria in blood cultures. Manuel C, Maynard R, Simpkins S, Haro M, Humphries R. J Clin Microbiol; 2024 Oct 16; 62(10):e0102024. PubMed ID: 39297627 [Abstract] [Full Text] [Related]
14. Phenotypic and genotypic characterization of extended-spectrum b-lactamases producing Escherichia coli and Klebsiella pneumoniaein a tertiary care hospital in Riyadh, Saudi Arabia. Somily AM, Arshad MZ, Garaween GA, Senok AC. Ann Saudi Med; 2015 Oct 16; 35(6):435-9. PubMed ID: 26657226 [Abstract] [Full Text] [Related]
17. Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of blaCTX-M Genes and Possible Interspecies Clonal Spread of Extended-Spectrum β-Lactamases-Producing Escherichia coli. Hasan B, Laurell K, Rakib MM, Ahlstedt E, Hernandez J, Caceres M, Järhult JD. Microb Drug Resist; 2016 Dec 16; 22(8):682-687. PubMed ID: 27007258 [Abstract] [Full Text] [Related]
20. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S. Mikrobiyol Bul; 2008 Oct 16; 42(4):537-44. PubMed ID: 19149074 [Abstract] [Full Text] [Related] Page: [Next] [New Search]